FLUORESCEIN SODIUM & BENOXINATE HYDROCHLORIDE OPHTHALMIC SOLUTION, USP
FLUORESCEIN SODIUM & BENOXINATE HYDROCHLORIDE OPHTHALMIC SOLUTION, USP
Dormant
DIN Number
02237775
Drug Class
Human
Market Date
Oct 27, 1998
Company
HC
bausch & lomb inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02237775
AIG Number0207547001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
S01JA51 FLUORESCEIN, COMBINATIONS
Product Specifications
Dosage FormSolution
Route of AdministrationOphthalmic
AHFS Classification52:16.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
BENOXINATE HYDROCHLORIDEActive
Strength: 0.4 %
Monograph: BENOXINATE HYDROCHLORIDE
FLUORESCEIN SODIUMActive
Strength: 0.25 %
Monograph: FLUORESCEIN SODIUM